IL6 and cancer: Although it is widely accepted that IL-6 and OSM promote EMP in many cancer types, the data gathered in this review further suggest that both promote different EMP programmes depending on the cancer type and the experimental setting, giving rise to cells with intermediate phenotypes within the epithelium–mesenchymal spectrum rather than generating complete mesenchymal cells with no epithelial features.